Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Myeloma
Closed
Phase 3
This trial is looking at a new drug called elotuzumab in people with multiple myeloma (MM) who have not had treatment yet.
Recruitment start: 5 July 2012
Recruitment end: 30 September 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Atul Mehta
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 27 November 2013
CRUK internal database number: 9340
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
